Precision BioSciences (DTIL) CSO discloses stock and RSU awards
Rhea-AI Filing Summary
Precision BioSciences Inc reports that Chief Scientific Officer Cassandra Louise Gorsuch directly owns 16,028 shares of Common Stock, fully vested employee stock options over 235 shares at $36.0000 and 585 shares at $359.4000, and Restricted Stock Units covering 40,000 and 179,340 shares that vest in three substantially equal annual installments beginning in 2026 and 2027, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Gorsuch Cassandra Louise
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Restricted Stock Units F3, F2 | -- | -- | -- |
| holding | Restricted Stock Units F3, F4 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 820 shares (Direct);
Restricted Stock Units — 219,340 shares (Direct);
Common Stock — 16,028 shares (Direct)
Footnotes (4)
- F1. Stock options are fully vested as of the date of this report
- F2. On June 2, 2025, the reporting person was granted 60,000 restricted stock units ("RSUs"), which vest in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
- F3. The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.
- F4. On June 1, 2026, the reporting person was granted 179,340 RSUs, which vest in three substantially equal annual installments beginning on February 19, 2027, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Key Figures
Common Stock holdings: 16,028 shares
Option exercise price: $36.0000 per share
Underlying shares at $36.0000: 235 shares
+4 more
7 metrics
Common Stock holdings
16,028 shares
Direct ownership of Precision BioSciences Common Stock reported for Cassandra Louise Gorsuch
Option exercise price
$36.0000 per share
Employee Stock Option over 235 underlying Common Stock shares expiring 2026-08-10
Underlying shares at $36.0000
235 shares
Common Stock underlying fully vested employee stock option held directly
Option exercise price
$359.4000 per share
Employee Stock Option over 585 underlying Common Stock shares expiring 2028-10-11
Underlying shares at $359.4000
585 shares
Common Stock underlying fully vested employee stock option held directly
Restricted Stock Units grant 2025
40,000 units
Outstanding RSUs from June 2, 2025 grant vesting in three substantially equal annual installments from February 17, 2026
Restricted Stock Units grant 2026
179,340 units
Outstanding RSUs from June 1, 2026 grant vesting in three substantially equal annual installments from February 19, 2027
Key Terms
Restricted Stock Units, Employee Stock Option (Right to Buy), contingent right, substantially equal annual installments
4 terms
Restricted Stock Units financial
"the reporting person was granted 60,000 restricted stock units (RSUs)"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Option (Right to Buy) financial
"security_title: Employee Stock Option (Right to Buy) with Common Stock underlying"
contingent right financial
"RSUs each represents a contingent right to receive one share of Common Stock"
substantially equal annual installments financial
"RSUs vest in three substantially equal annual installments beginning on specific dates"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity holdings does Cassandra Louise Gorsuch report in DTIL?
Cassandra Louise Gorsuch reports 16,028 shares of Precision BioSciences Common Stock, employee stock options over 235 and 585 underlying shares, and Restricted Stock Units covering 40,000 and 179,340 shares, all held as direct ownership.
What stock options does the Precision BioSciences CSO hold?
She holds fully vested employee stock options over 235 underlying shares at an exercise price of $36.0000 per share and over 585 underlying shares at $359.4000 per share, both covering Precision BioSciences Common Stock and held as direct ownership.
What RSU awards are outstanding for the DTIL Chief Scientific Officer?
The CSO has Restricted Stock Units covering 40,000 shares from a June 2, 2025 grant and 179,340 shares from a June 1, 2026 grant. Each RSU represents a contingent right to receive one share of Precision BioSciences Common Stock upon vesting.
When do Cassandra Louise Gorsuch’s RSUs in DTIL begin vesting?
RSUs from the June 2, 2025 grant vest in three substantially equal annual installments beginning on February 17, 2026. RSUs from the June 1, 2026 grant vest similarly, beginning on February 19, 2027, in each case subject to her continued service to the company.
How do the RSUs reported by the DTIL CSO convert into common stock?
Each Restricted Stock Unit reported by the CSO represents a contingent right to receive one share of Precision BioSciences Common Stock. Shares are delivered upon vesting of the RSUs, assuming satisfaction of the continued service conditions described in the award terms.